21 CFR 862, Subpart D - Clinical Toxicology Test Systems
- § 862.3030 — Acetaminophen test system.
- § 862.3035 — Amikacin test system.
- § 862.3040 — Alcohol test system.
- § 862.3050 — Breath-alcohol test system.
- § 862.3080 — Breath nitric oxide test system.
- § 862.3100 — Amphetamine test system.
- § 862.3110 — Antimony test system.
- § 862.3120 — Arsenic test system.
- § 862.3150 — Barbiturate test system.
- § 862.3170 — Benzodiazepine test system.
- § 862.3200 — Clinical toxicology calibrator.
- § 862.3220 — Carbon monoxide test system.
- § 862.3240 — Cholinesterase test system.
- § 862.3250 — Cocaine and cocaine metabolite test system.
- § 862.3270 — Codeine test system.
- § 862.3280 — Clinical toxicology control material.
- § 862.3300 — Digitoxin test system.
- § 862.3320 — Digoxin test system.
- § 862.3350 — Diphenylhydantoin test system.
- § 862.3360 — Drug metabolizing enzyme genotyping system.
- § 862.3380 — Ethosuximide test system.
- § 862.3450 — Gentamicin test system.
- § 862.3520 — Kanamycin test system.
- § 862.3550 — Lead test system.
- § 862.3555 — Lidocaine test system.
- § 862.3560 — Lithium test system.
- § 862.3580 — Lysergic acid diethylamide (LSD) test system.
- § 862.3600 — Mercury test system.
- § 862.3610 — Methamphetamine test system.
- § 862.3620 — Methadone test system.
- § 862.3630 — Methaqualone test system.
- § 862.3640 — Morphine test system.
- § 862.3645 — Neuroleptic drugs radioreceptor assay test system.
- § 862.3650 — Opiate test system.
- § 862.3660 — Phenobarbital test system.
- § 862.3670 — Phenothiazine test system.
- § 862.3680 — Primidone test system.
- § 862.3700 — Propoxyphene test system.
- § 862.3750 — Quinine test system.
- § 862.3830 — Salicylate test system.
- § 862.3840 — Sirolimus test system.
- § 862.3850 — Sulfonamide test system.
- § 862.3870 — Cannabinoid test system.
- § 862.3880 — Theophylline test system.
- § 862.3900 — Tobramycin test system.
- § 862.3910 — Tricyclic antidepressant drugs test system.
- § 862.3950 — Vancomycin test system.
Title 21 published on 2012-04-01
The following are only the Rules published in the Federal Register after the published date of Title 21.
For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
§ 360c - Classification of devices intended for human use
§ 360e - Premarket approval
§ 360i - Records and reports on devices
§ 360j - General provisions respecting control of devices intended for human use
Title 21 published on 2012-04-01
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR 862 after this date.
GPO FDSys XML | Text type regulations.gov FR Doc. 2013-06826 RIN Docket No. FDA-2013-N-0011 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final rule; technical amendment. This rule is effective March 26, 2013. 21 CFR Parts 814, 822, 862, 864, 866, 868, 870, 872, 874, 876, 878, 880, 882, 884, 886, 888, 890, and 892 The Food and Drug Administration (FDA) is amending certain medical device regulations to correct minor errors in the Code of Federal Regulations (CFR). This action is editorial in nature and is intended to provide accuracy and clarity to the Agency's regulations.